The Influence of Age on the Efficacy of a Novel Antidiabetic Drug Imeglimin in Patients With Poorly Controlled Type 2 Diabetes

Journal of Endocrinology and Metabolism · Published 2026-06-01 · DOI 10.14740/jem1637

Free full text

Authors (8)

Masataka Kusunoki, Fumiya Hisano, Shin-ichi Matsuda, Kohei Kunitsu, Daijiro Miyanaga, Masaaki Kusunoki, Kazuhiko Tsutsumi, Tetsuro Miyata

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Kusunoki, M., Hisano, F., Matsuda, S., et al. (2026). The Influence of Age on the Efficacy of a Novel Antidiabetic Drug Imeglimin in Patients With Poorly Controlled Type 2 Diabetes. Journal of Endocrinology and Metabolism. https://doi.org/10.14740/jem1637

Related articles

• Epidemiology of Metabolic Dysfunction-Associated Fatty Liver Disease in Type 2 Diabetes Mellitus and Effects of Antiglycemic Therapy on Liver Fibrosis: A Retrospective Study · Journal of Endocrinology and Metabolism · 2024 · Same journal
• Efficacy of Second Radioactive Iodine Therapy Based on Serum Thyroglobulin for Papillary Thyroid Cancer: A Retrospective Cohort Study · Journal of Endocrinology and Metabolism · 2025 · Same journal
• Mesenchymal Stem Cell in Thyroid Disorders: Hype or Hope? · Journal of Endocrinology and Metabolism · 2025 · Same journal
• Pharmacological Treatment of Diabetes Mellitus: An Overview of New Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Diabetes Mellitus · Journal of Endocrinology and Metabolism · 2024 · Same journal
• Dyslipidemia Prevalence and Risk Factors in Al Ain: A Retrospective Cross-Sectional Analysis · Journal of Endocrinology and Metabolism · 2025 · Same journal
• Increased Prevalence of Advanced Metabolic Dysfunction-Associated Steatotic Liver Disease Fibrosis in Type 2 Diabetics Despite Low-Risk Fibrosis-4 Index Scores · Journal of Endocrinology and Metabolism · 2024 · Same journal
• The Cardiometabolic Clinic: Bridging Gaps in Care · Journal of Endocrinology and Metabolism · 2024 · Same journal
• Systemic Acetate Is a Potential Biomarker of Metabolic Health and Therapeutic Response: A Pilot Cross-Sectional Investigation · Journal of Endocrinology and Metabolism · 2024 · Same journal
• Role of Adiponectin in Modulating Insulin Resistance in Visceral Obesity-Associated Type 2 Diabetes Mellitus · Journal of Endocrinology and Metabolism · 2025 · Same journal
• Prevalence of Self-Reported Halitosis in Individuals With Type 1 and Type 2 Diabetes Mellitus: A Cross-Sectional Study · Journal of Endocrinology and Metabolism · 2025 · Same journal